The 2 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 31.00, with a high estimate of 35.00 and a low estimate of 27.00. The median estimate represents a +26.58% increase from the last price of 24.49.
The current consensus among 4 polled investment analysts is to Buy stock in AngioDynamics Inc. This rating has held steady since October, when it was upgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.02
Reporting Date Oct 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.